Synthesis and antibacterial activity of oxazolidinones containing triazolyl group

European Journal of Medicinal Chemistry

Volumn 42, Issue 8, 2007, Pages 1137-1143

  Fan, Houxing ^a   Xu, Gang ^a   Chen, Yilang ^a   Jiang, Zhiteng ^a   Zhang, Shuhua ^b   Yang, Yushe ^a   Ji, Ruyun ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b Sichuan Industrial Institute of Antibiotics   (China)

Author keywords

Antibacterial agents; Gram positive organisms; Linezolid; Oxazolidinone

Indexed keywords

5 ((1H 1,2,3 TRIAZOL 1 YL)METHYL) 3 (3 FLUORO 4 (4 (3 FLUOROPHENYLSULFONYL)PIPERAZIN 1 YL)PHENYL)OXAZOLIDIN 2 ONE; 5 ((1H 1,2,3 TRIAZOL 1 YL)METHYL) 3 (3 FLUORO 4 (4 (3 NITROPHENYLSULFONYL)PIPERAZIN 1 YL)PHENYL)OXAZOLIDIN 2 ONE; 5 [(1H 1,2,3 TRIAZOL 1 YL)METHYL] 3 [3 FLUORO 4 [4 (3 AMINOPHENYLSULFONYL)PIPERAZIN 1 YL]PHENYL]OXAZOLIDIN 2 ONE; LINEZOLID; OXAZOLIDINONE DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 34447534369     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.01.012     Document Type: Article

References (18)

1. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., and Beach M.L. Diagn. Microbiol. Infect. Dis. 33 4 (1999) 283-297
2. Abi-Hanna P., Frank A.L., Quinn J.P., Kelkar S., Schreckenberger P.C., Hayden M.K., and Marcinak J.F. Clin. Infect. Dis. 30 3 (2000) 630-631
3. Collignon P. J. Infect. Dis. 179 6 (1999) 1592
4. Merlino J., Leroi M., Bradbury R., Veal D., and Harbour C. J. Clin. Microbiol. 38 (2000) 2378-2380
5. Cookson B.D. Infect. Control Hosp. Epidemiol. 21 6 (2000) 398-403
6. Clemett D., and Markham A. Drugs 59 4 (2000) 815-827
7. Swaney S.M., Aoki H., Ganoza M.C., and Shinabarger D.L. Antimicrob. Agents Chemother. 42 (1998) 3251-3255 and references cited therein
8. Aoki H., Ke L., Poppe S.M., Poel T.J., Weaver E.A., Gadwood R.C., Thomas R.C., Shinabarger D.L., and Ganoza M.C. Antimicrob. Agents Chemother. 46 (2002) 1080-1085 and references cited therein
9. Tsirodas S., Gold H.S., Sakoulas G., Eliopoulas G.M., Wennerstein C., Venkataraman L., Moellering Jr. R.C., and Ferro M.J. Lancet 358 (2001) 207-208
10. Johnson A.P., Tysall L., Stockdale M.W., Woodford N., Kaufmann M.E., Warner M., Livermoore D.M., Asboth F., and Alleberger F.J. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 751-754
11. Yingjie C., Yushe Y., Ruyun J., and Shuhua Z.H. Bioorg. Med. Chem. Lett. 13 14 (2003) 2311-2313
12. Phillips O.A., Udo E.E., Ali A.A.M., and Al-Hassawi N. Bioorg. Med. Chem. 11 1 (2003) 35-41
13. Ramsay R.R., and Gravestock M.B. Mini Rev. Med. Chem. 3 2 (2003) 129-136
14. Brickner S.J., Hutchinson D.K., Barbachyn M.R., Manninen P.R., Ulanowicz D.A., Garmon S.A., Grega K.C., Hendges S.K., Toops D.S., Ford C.W., and Zurenko G.E. J. Med. Chem. 39 3 (1996) 673-679
15. Genin M.J., Allwine D.A., Anderson D.J., Barbachyn M.R., Emmert D.E., Garmon S.A., Graber D.R., Grega K.C., Hester J.B., Hutchinson D.K., Morris J., Reischer R.J., Ford C.W., Zurenko G.E., Hamel J.C., Schaadt R.D., Stapert D., and Yagi B.H. J. Med. Chem. 43 5 (2000) 953-970
16. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grows Aerobically. fourth ed. (1997), National Committee for Clinical Laboratory Standards, Villanova, PA, USA Approved standards: NCCLS Document M7-A4
17. Bliss C.I. Science 79 (1934) 38-39
18. Bliss C.I. Ann. Appl. Biol. 22 (1935) 134-167